U.S. Abbvie, Lionsgate Studios, UnitedHealth Group
June 5 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Abbvie, Lionsgate Studios and UnitedHealth Group, on Wednesday.
HIGHLIGHTS
* Abbvie Inc ABBV.N: HSBC raises to buy from hold |
* Crowdstrike Holdings Inc CRWD.O: BTIG cuts target price to $402 from $432 |
* Lionsgate Studios LION.O: Seaport Research Partners initiates coverage with neutral rating |
* Sunoco LP SUN.N: JP Morgan assumes coverage with overweight vs neutral rating |
* UnitedHealth Group Inc UNH.N: HSBC raises to buy from hold |
Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.
* Abbvie Inc ABBV.N: HSBC raises target price to $185 from $161 |
* Abbvie Inc ABBV.N: HSBC raises to buy from hold |
* Adobe Inc ADBE.O: RBC cuts target price to $600 from $630 |
* Air Products and Chemicals Inc APD.N: Morgan Stanley raises PT to $280 from $240 |
* Alnylam Pharmaceuticals Inc ALNY.O: JP Morgan cuts target price to $160 from $166 |
* American Financial Group Inc AFG.N: Citigroup cuts target price to $144 from $145 |
* Annexon Inc ANNX.O: JP Morgan raises target price to $12 from $11 |
* Applied Materials Inc AMAT.O: Barclays raises target price to $225 from $165 |
* Applied Materials Inc AMAT.O: Barclays raises to equal-weight from underweight |
* Aramark ARMK.N: Jefferies raises target price to $37 from $35 |
* Aris Water Solutions Inc ARIS.N: Citigroup raises target price to $18 from $14 |
* Aspen Aerogels Inc ASPN.N: TD Cowen raises target price to $36 from $30 |
* Axsome Therapeutics Inc AXSM.O: RBC raises target price to $130 from $127 |
* Bath & Body Works Inc BBWI.N: BMO raises target price to $55 from $50 |
* Boot Barn Holdings Inc BOOT.N: BTIG raises target price to $150 from $125 |
* Boot Barn Holdings Inc BOOT.N: Craig-Hallum raises target price to $150 from $120 |
* Boot Barn Holdings Inc BOOT.N: TD Cowen raises target price to $145 from $120 |
* Boston Beer Company Inc SAM.N: Morgan Stanley raises to equal-weight from underweight |
* Braze Inc BRZE.O: Citigroup cuts target price to $52 from $65 |
* Bridgebio pharma Inc BBIO.O: JP Morgan raises target price to $46 from $44 |
* Citi Trends, Inc CTRN.O: Craig-Hallum cuts target price to $25 from $27 |
* Conocophillips COP.N: Mizuho cuts target price to $132 from $142 |
* Core & Main Inc CNM.N: Truist Securities cuts target price to $50 from $56 |
* Crowdstrike Holdings Inc CRWD.O: Bernstein cuts target price to $381 from $397 |
* Crowdstrike Holdings Inc CRWD.O: BMO cuts target price to $410 from $425 |
* Crowdstrike Holdings Inc CRWD.O: BTIG cuts target price to $402 from $432 |
* Crowdstrike Holdings Inc CRWD.O: Canaccord Genuity raises PT to $405 from $400 |
* Crowdstrike Holdings Inc CRWD.O: D.A. Davidson cuts target price to $380 from $425 |
* Crowdstrike Holdings Inc CRWD.O: Mizuho cuts target price to $370 from $390 |
* Crowdstrike Holdings Inc CRWD.O: Scotiabank cuts target price to $393 from $400 |
* Crowdstrike Holdings Inc CRWD.O: Wedbush cuts target price to $385 from $390 |
* Crowdstrike Holdings Inc CRWD.O: Oppenheimer raises target price to $400 from $355 |
* Darden Restaurants Inc DRI.N: Citigroup cuts target price to $191 from $192 |
* Designer Brands Inc DBI.N: Telsey Advisory Group cuts target price to $10 from $11 |
* Docusign Inc DOCU.O: Citigroup cuts target price to $86 from $93 |
* Donaldson Company Inc DCI.N: Jefferies raises target price to $81 from $77 |
* Entergy Corp ETR.N: Wells Fargo raises target price to $125 from $122 |
* Entergy Corp ETR.N: Barclays raises target price to $116 from $107 |
* Evgo Inc EVGO.O: Benchmark initiates coverage with buy rating; target price $3 |
* Factset Research Systems Inc FDS.N: Jefferies cuts target price to $378 from $455 |
* Ferguson FERG.N: Barclays cuts target price to $232 from $236 |
* Ferguson FERG.N: Jefferies cuts target price to $238 from $244 |
* Ferguson FERG.N: RBC cuts target price to $211 from $217 |
* Glaukos Corp GKOS.N: Stifel raises target price to $130 from $110 |
* Guidewire Software Inc GWRE.N: BofA Global Research raises price objective to $95 from $80 |
* Guidewire Software Inc GWRE.N: BTIG raises target price to $140 from $135 |
* Guidewire Software Inc GWRE.N: Citigroup raises target price to $123 from $122 |
* Guidewire Software Inc GWRE.N: JP Morgan raises target price to $145 from $133 |
* Guidewire Software Inc GWRE.N: Raymond James raises target price to $130 from $125 |
* Guidewire Software Inc GWRE.N: Stifel raises target price to $140 from $130 |
* Guidewire Software Inc GWRE.N: Wells Fargo raises target price to $140 from $130 |
* Guidewire Software Inc GWRE.N: Oppenheimer raises target price to $140 from $130 |
* Healthequity Inc HQY.O: Deutsche Bank raises target price to $102 from $95 |
* Hewlett Packard Enterprise HPE.N: Morgan Stanley raises PT to $21.00 from $19.00 |
* Hewlett Packard Enterprise Co HPE.N: Bernstein raises target price to $19 from $17 |
* Hewlett Packard Enterprise Co HPE.N: BofA Global Research raises price objective to $22 from $19 |
* Hewlett Packard Enterprise Co HPE.N: Evercore ISI raises target price to $22 from $18 |
* Hewlett Packard Enterprise Co HPE.N: Morgan Stanley raises target price to $21 from $19 |
* Hewlett Packard Enterprise Co HPE.N: Raymond James raises target price to $23 from $19 |
* Hewlett Packard Enterprise Co HPE.N: Stifel raises target price to $22 from $18 |
* Hewlett Packard Enterprise Co HPE.N: Susquehanna raises target price to $20 from $14 |
* Hewlett Packard Enterprise Co HPE.N: Wells Fargo raises target price to $22 from $19 |
* Hewlett Packard Enterprise Co HPE.N: Barclays raises target price to $20 from $14 |
* Honeywell International Inc HON.O: Daiwa Capital Markets raises PT to $217 from $200 |
* Hookipa pharma Inc HOOK.O: H.C. Wainwright raises target price to $6 from $5 |
* Hyster-Yale Inc HY.N: Northland Capital raises to outperform from market perform |
* Ideaya Biosciences Inc IDYA.O: JP Morgan raises target price to $65 from $55 |
* Illinois Tool Works Inc ITW.N: JP Morgan cuts target price to $275 from $280 |
* Insmed Inc INSM.O: Stifel raises target price to $74 from $67 |
* Ionis Pharmaceuticals Inc IONS.O: JP Morgan cuts target price to $50 from $55 |
* Keurig DR Pepper Inc KDP.O: Wells Fargo raises target price to $41 from $39 |
* Kla Corporation KLAC.O: Barclays raises target price to $765 from $630 |
* Kla Corporation KLAC.O: Barclays raises to equal-weight from underweight |
* Labcorp LH.N: HSBC cuts target price to $210 from $225 |
* Lam Research Corporation LRCX.O: Barclays raises target price to $900 from $865 |
* Leonardo Drs Inc DRS.O: Truist Securities raises target price to $27 from $25 |
* Lifemd Inc LFMD.O: KeyBanc initiates coverage with overweight rating and PT $12 |
* Lionsgate Studios LION.O: Seaport Research Partners initiates coverage with neutral rating |
* Magnite Inc MGNI.O: RBC raises target price to $19 from $17 |
* Mainz Biomed NV MYNZ.O: Jonestrading cuts target price to $4 from $8 |
* Marathon Oil Corp MRO.N: Mizuho raises target price to $34 from $33 |
* Medifast Inc MED.N: D.A. Davidson cuts target price to $17.5 from $25 |
* Medifast Inc MED.N: D.A. Davidson cuts to underperform from neutral |
* Merck & Co Inc MRK.N: HSBC raises target price to $130 from $118 |
* Meta META.O: Raymond James raises target price to $550 from $525 |
* Moog Inc MOGa.N: TD Cowen raises target price to $208 from $187 |
* Nextera Energy, Inc. NEE.N: Barclays raises target price to $74 from $66 |
* Old Dominion Freight Line Inc ODFL.O: BMO initiates coverage with outperform rating |
* Old Dominion Freight Line Inc ODFL.O: BMO initiates coverage with target price $210 |
* One Gas Inc OGS.N: Mizuho raises target price to $65 from $64 |
* Paylocity Holding Corp PCTY.O: Stifel cuts target price to $185 from $205 |
* PG&E Corporation PCG.N: Barclays raises target price to $22 from $21 |
* Phreesia Inc PHR.N: Jefferies cuts target price to $28 from $32 |
* Pinnacle West Capital Corp PNW.N: Wells Fargo raises target price to $80 from $77 |
* Procore Technologies Inc PCOR.N: Macquarie initiates coverage with neutral rating |
* Procore Technologies Inc PCOR.N: Macquarie initiates coverage with target price $70 |
* Progressive Corp PGR.N: Citigroup cuts target price to $230 from $232 |
* PVH Corp PVH.N: BMO raises target price to $119 from $110 |
* PVH Corp PVH.N: Evercore ISI raises target price to $145 from $140 |
* PVH Corp PVH.N: Wedbush raises target price to $143 from $128 |
* Root Inc ROOT.O: TD Cowen raises target price to $51 from $11 |
* Sensei Biotherapeutics Inc SNSE.O: Citigroup resumes coverage with buy rating; PT $4 |
* Sentinelone Inc S.N: Citigroup cuts target price to $20 from $25 |
* Siteone Landscape Supply Inc SITE.N: Barclays cuts target price to $129 from $133 |
* Siteone Landscape Supply Inc SITE.N: Barclays cuts target price to $129 from $133 |
* Snowflake Inc SNOW.N: Mizuho cuts target price to $180 from $205 |
* Snowflake Inc SNOW.N: RBC cuts target price to $183 from $226 |
* Spire Global Inc SPIR.N: Craig-Hallum initiates coverage with buy rating |
* Spire Global Inc SPIR.N: Craig-Hallum initiates coverage with target price $13 |
* Sportsmans Warehouse Holdings Inc SPWH.O: Craig-Hallum cuts target price to $4 from $5 |
* Steven Madden Ltd SHOO.O: Jefferies raises target price to $42 from $39 |
* Stitch Fix Inc SFIX.O: Truist Securities raises target price to $4 from $3.50 |
* Sunoco LP SUN.N: JP Morgan assumes coverage with overweight vs neutral rating |
* Sunoco LP SUN.N: JP Morgan assumes coverage with target price $61 vs $60 |
* Thor Industries Inc THO.N: CFRA cuts target price to $90 from $100 |
* U.S. Goldmining Inc. USGO.O: H.C. Wainwright raises target price to $23.5 from $23 |
* UnitedHealth Group Inc UNH.N: HSBC raises target price to $580 from $460 |
* UnitedHealth Group Inc UNH.N: HSBC raises to buy from hold |
* Verint Systems Inc VRNT.O: Jefferies raises target price to $32 from $30 |
* Viasat VSAT.O: Barclays cuts target price to $24 from $28 |
* Viking Therapeutics Inc VKTX.O: Leerink Partners raises PT to $118 from $115 |
* Vir Biotechnology Inc VIR.O: JP Morgan raises target price to $13 from $12 |
* Zscaler Inc ZS.O: Citigroup cuts target price to $240 from $270 |
(Compiled by Bengaluru Newsroom)
</body></html>Související aktiva
Poslední novinky
Zřeknutí se odpovědnosti: Subjekty skupiny XM Group poskytují služby a přístup do naší online obchodní platformy v režimu „execution-only”, což osobám umožní prohlížet a/nebo použít obsah, dostupný zde nebo prostřednictvím webové stránky, který není určený ke změně nebo šíření. Na takový přístup a použití se vždy vztahují: (i) Všeobecné obchodní podmínky; (ii) Upozornění na rizika; a (iii) Úplné zřeknutí se odpovědnosti. Takový obsah je proto poskytovaný pouze jako obecné informace. Mějte především na paměti, že obsah naší online obchodní platformy není ani žádostí, ani nabídkou vstupu do jakýchkoliv transakcí na finančních trzích. Obchodování na jakémkoliv finančním trhu zahrnuje významnou úroveň rizika pro váš kapitál.
Veškerý materiál, zveřejněný na naší online obchodní platformě, je určený pouze pro vzdělávací/informační účely a neobsahuje ani by neměl být považovaný za finanční, investiční, daňové nebo obchodní rady a doporučení, ani záznamy o našich obchodních cenách, nebo nabídku transakce s jakýmikoliv finančními instrumenty, či nevyžádadnou propagaci pro vaši osobu.
Jakýkoliv obsah třetích stran a také obsah, připravený společností XM, jako jsou názory, novinky, výzkum, analýzy, ceny, další informace nebo odkazy na webové stránky třetích stran, které jsou zobrazeny na tomto webu, jsou poskytovány v neupravené verzi jako obecný tržní komentář, a nepředstavují investiční radu. Pokud je jakýkoliv obsah uváděný jako investiční výzkum, musíte si uvědomit a přijmout, že tento obsah nebyl určený a nebyl připravený v souladu se zákonnými požadavky, vytvořenými pro podporu nezávislosti investičního výzkumu, a jako takový by měl být podle příslušných zákonů a předpisu považovaný pouze za marketingovou komunikaci. Ujistěte se, že jste si přečetli a plně rozumíte našemu Oznámení o seznámení se s riziky a investičním výzkumu, který není nezávislý, týkající se výše uvedených informací, a ke kterým lze přejít zde.
